In Case You Missed It: NACDS, CPANYS Continue to Laud New York’s Medicaid “Promise Kept”
Implementation of NYRx New York Medicaid pharmacy benefit celebrated.
Implementation of NYRx New York Medicaid pharmacy benefit celebrated.
Study reflects “NACDS 2023” focus on adding value to NACDS members’ innovation of health and wellness in the pharmacy and beyond.
NACDS is lauding legislation introduced by U.S. Senators Peter Welch (D-VT) and Roger Marshall (R-KS) to crack down on tactics by which “pharmaceutical benefit manipulator” middlemen maximize profits at the expense of patients, pharmacies, and others.
NYRx puts patients over PBMs in the state’s Medicaid pharmacy benefit.
The Drug Price Transparency in Medicaid Act will protect patients, pharmacies, and others from middlemen tactics that drive up prescription drug prices.
The decision offers hope for the ability of pharmacies to continue to meet patients’ needs in Washington State and across the nation.
Calls on the Center for Medicare and Medicaid Innovation to integrate pharmacies and pharmacists into value-based programs and alternative payment models to accelerate mission toward better outcomes and lower costs.
Pharmacy groups applaud this victory for pharmacies and patient access to care .
The Washington State Pharmacists Association, the National Community Pharmacists Association, and the National Association of Chain Drug Stores today cheered a move by the Department of Justice that could signal victory in their case against unfairly low reimbursements for pharmacies that treat Medicaid patients.
Newly-enacted laws empower pharmacists to focus their time on patients and clinical care, extend Iowans’ access to routine vaccinations and point-of-care testing; Iowa Governor takes action to protect viability of community retail pharmacies throughout the state and the patients they serve.